Intelligent Bio Solutions Inc
(INBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 0 | 1,608 | 34 |
| Gross Profit | 0 | N/A | N/A | 1,608 | 34 |
| Operating Expenses | 1,343 | 3,467 | 1,439 | 2,460 | 3,175 |
| Operating Income | -1,343 | -3,467 | -1,439 | -853 | -3,141 |
| Interest Expense | 4 | 1 | 0 | 2 | 19 |
| Other Income | 3 | 4 | 2 | 5 | 16 |
| Pre-tax Income | -1,344 | -3,464 | -1,438 | -850 | -3,143 |
| Net Income Continuous | -1,344 | -3,464 | -1,438 | -850 | -3,143 |
| Minority Interests | -9 | -4 | -5 | 3 | -15 |
| Net Income | $-1,335 | $-3,460 | $-1,433 | $-853 | $-3,128 |
| EPS Basic Total Ops | -214.89 | -558.22 | -240.10 | -144.06 | -648.26 |
| EPS Basic Continuous Ops | -216.59 | -558.81 | -246.48 | -134.10 | -639.67 |
| EPS Diluted Total Ops | -214.89 | -558.22 | -240.10 | -144.06 | -648.26 |
| EPS Diluted Continuous Ops | -216.59 | -558.81 | -246.48 | -134.10 | -639.67 |
| EBITDA(a) | $-1,343 | $-3,467 | $-1,439 | $-853 | $-3,141 |